| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 20.01▼ | 20.07▼ | 20.00▼ | 20.15▼ | 24.75▼ |
| MA10 | 20.06▼ | 20.02▼ | 20.00▼ | 22.18▼ | 26.57▼ |
| MA20 | 20.09▼ | 20.00▼ | 20.06▼ | 24.86▼ | 25.03▼ |
| MA50 | 20.04▼ | 20.10▼ | 20.72▼ | 26.95▼ | 24.26▼ |
| MA100 | 20.03▼ | 21.05▼ | 23.79▼ | 25.03▼ | 22.02▼ |
| MA200 | 20.03▼ | 24.08▼ | 26.23▼ | 24.40▼ | 21.44▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.022▼ | 0.016▲ | 0.090▲ | -0.678▼ | -0.654▼ |
| RSI | 37.030▼ | 45.783▼ | 40.745▼ | 16.326▼ | 35.442▼ |
| STOCH | 14.999▼ | 47.034 | 53.600 | 4.701▼ | 38.596 |
| WILL %R | -93.878▼ | -78.873▼ | -44.444 | -95.750▼ | -96.834▼ |
| CCI | -169.591▼ | -44.696 | 30.854 | -81.044 | -211.241▼ |
|
Tuesday, September 29, 2026 02:28 PM
Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD). Such investors are advised to contact Danielle Peyton at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/10/26 | 20.00 | 20.24 | 19.875 | 19.95 | 2,222,765 |
| 01/10/26 | 19.95 | 20.19 | 19.59 | 19.89 | 2,731,696 |
| 30/09/26 | 20.275 | 20.70 | 19.93 | 20.15 | 3,134,008 |
| 29/09/26 | 20.605 | 20.605 | 20.06 | 20.22 | 2,512,869 |
| 28/09/26 | 20.53 | 20.63 | 19.80 | 20.53 | 3,434,544 |
| 25/09/26 | 22.21 | 22.21 | 20.61 | 20.68 | 3,362,294 |
| 24/09/26 | 24.38 | 24.38 | 21.97 | 22.18 | 6,637,289 |
| 23/09/26 | 26.41 | 26.51 | 24.93 | 25.43 | 1,305,764 |
| 22/09/26 | 26.65 | 26.855 | 26.32 | 26.41 | 1,442,433 |
| 21/09/26 | 27.43 | 27.43 | 26.34 | 26.395 | 1,351,906 |
|
|
||||
|
|
||||
|
|